Design of a study of semaglutide in psychiatry, with Roger S. McIntyre, MD
Although their clinical benefit for cardiometabolic, renal, hepatic, and obesity medicine may seem too good to be true, the GLP-1 and GIP receptor agonist incretin therapy drug classes are proving …